Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700030558

Trial Profile

Clinical Trials Insight: 700030558

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 28 May 2008

At a glance

  • Drugs Dextromethorphan/quinidine (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Pharmacokinetics
  • Sponsors Avanir Pharmaceuticals
  • Most Recent Events

    • 28 May 2008 Status changed from recruiting to in progress, according to an Avanir media release.
    • 28 May 2008 Top-line results have been reported in April 2008 in an Avanir media release.
    • 13 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top